Rakuten Investment Management Inc. Makes New Investment in Cigna Group $CI

Rakuten Investment Management Inc. bought a new stake in shares of Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 43,217 shares of the health services provider’s stock, valued at approximately $12,046,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the fourth quarter valued at approximately $25,000. Osbon Capital Management LLC bought a new stake in shares of Cigna Group in the 2nd quarter valued at approximately $26,000. Johnson Financial Group Inc. purchased a new position in shares of Cigna Group in the 2nd quarter worth approximately $29,000. Kemnay Advisory Services Inc. bought a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Finally, Prosperity Bancshares Inc bought a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 19,436 shares of the firm’s stock in a transaction on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the transaction, the insider owned 27,256 shares in the company, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 23,012 shares of company stock worth $6,386,550 in the last three months. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Stock Performance

CI stock opened at $278.89 on Friday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. The business’s fifty day simple moving average is $283.52 and its two-hundred day simple moving average is $281.39. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market cap of $73.69 billion, a price-to-earnings ratio of 11.54, a PEG ratio of 0.96 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business’s revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio is presently 25.82%.

Analyst Upgrades and Downgrades

Several research analysts have commented on CI shares. Wells Fargo & Company lifted their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. UBS Group increased their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Barclays raised their target price on shares of Cigna Group from $304.00 to $310.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Sanford C. Bernstein upped their price target on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. Finally, The Goldman Sachs Group increased their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Fifteen analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.